Aretha-1 Initial Efficacy and Safety Data in mTNBC Patients To Be Presented at SABCS

Aretha-1 Initial Efficacy and Safety Data in mTNBC Patients To Be Presented at SABCS Safety Run-in Cohort Results Show Anti-tumor Activity Plus Systemic Metabolic Improvements with Evexomostat Plus Eribulin in Late-line Metastatic TNBC Patients to be Presented at SABCS 2025 Tagged Aretha-1 , eribulin , MSKCC , TNBC

The release as fetched from its publisher. syndevrx.com ↗